Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bolt Biotherapeutics (BOLT)
NASDAQ:BOLT
RESEARCH TOOLSreports
Holding BOLT?
Track your performance easily
See the Price Targets and Ratings of:
BOLT Analyst Ratings
Hold
0 Buy
3 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
BOLT Stock 12 Month Forecast
Average Price Target
$1.75
▲(208.64% Upside)
| Highest Price Target$2.00 | Average Price Target$1.75 | Lowest Price Target$1.50 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Leerink Partners
Reiterated
11/14/24
Stifel Nicolaus
Reiterated
11/13/24
H.C. Wainwright
Reiterated
11/13/24
JonesTrading
―
Hold
―
Reiterated
08/14/24
Hold Rating on Bolt Biotherapeutics Pending Clarity on Clinical Pipeline and Efficacy Data
Guggenheim
―
Hold
―
Downgraded
05/14/24
Bolt Biotherapeutics downgraded to Neutral from Buy at GuggenheimBolt Biotherapeutics downgraded to Neutral from Buy at Guggenheim
BOLT Analyst Recommendation Trends
Rating
Dec 23
Mar 24
May 24
Aug 24
Nov 24
Strong Buy
6
5
3
2
0
Buy
2
2
1
1
0
Hold
0
0
5
8
11
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
8
7
9
11
11
Each month's total comprises the sum of three months' worth of ratings.
BOLT Financial Forecast
BOLT Stock Forecast FAQ
What is BOLT’s average 12-month price target, according to analysts?
Based on analyst ratings, Bolt Biotherapeutics’s 12-month average price target is $1.75.
What is BOLT’s upside potential, based on the analysts’ average price target?
Bolt Biotherapeutics has 208.64% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is BOLT a Buy, Sell or Hold?
Bolt Biotherapeutics has a consensus rating of Hold which is based on 0 buy ratings, 3 hold ratings and 0 sell ratings.
What is Bolt Biotherapeutics’s price target?
The average price target for Bolt Biotherapeutics is $1.75. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $2.00 ,the lowest forecast is $1.50. The average price target represents 208.64% Increase from the current price of $0.567.
The highest analyst price target is $2.00 ,the lowest forecast is $1.50. The average price target represents 208.64% Increase from the current price of $0.567.
What do analysts say about Bolt Biotherapeutics?
Bolt Biotherapeutics’s analyst rating consensus is a Hold. This is based on the ratings of 3 Wall Streets Analysts.
How can I buy shares of BOLT?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.